Kezdőlap・Részvénylista・TransMedics Group Inc

TransMedics Group Inc

Lezárt

SzektorEgészségügy

89.48 3.29

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

85.57

Maximum

89.33

Fő mutatók
By Trading Economics
Bevétel	7.4M 15M
Értékesítés	16M 190M
P/E Szektor átlag	21.722 57.002
Egy részvényre jutó nyereség	0.44
Profit margin	7.729
Munkavállalók	898
EBITDA	-889K 27M

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+5.44% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. okt. 28.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	247M 3.1B
Előző nyitás	86.19
Előző zárás	89.48

Hangulat hírek alapján

By Acuity

100%

323 / 340 Rangsor szerint Healthcare

TransMedics Group Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 12. 19:36 UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

2026. aug. 11. 19:16 UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

2026. aug. 10. 19:21 UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

2026. aug. 7. 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

2026. aug. 6. 20:03 UTC

Social Media

News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

2026. aug. 5. 20:03 UTC

Social Media

News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

2026. aug. 4. 23:02 UTC

News

Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

2026. aug. 3. 19:51 UTC

Social Media

News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

2026. júl. 30. 19:03 UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

2026. júl. 29. 23:36 UTC

Transmedics Group Inc. shares are lower in after-market trading, reflecting broader market volatility amid rising interest rates and geopolitical tensions.

2026. júl. 28. 19:46 UTC

Transmedics Group Inc shares are higher today, advancing since Monday. The stock peaked earlier but pulled back from a session high.

2026. júl. 27. 15:16 UTC

Social Media

News

Transmedics Group Inc is higher today amid social media discussions on its undervaluation and expectations for significant profit by 2028.

2026. júl. 24. 20:02 UTC

Social Media

Transmedics Group Inc gains amid positive feedback from Jefferies on its technology and growth prospects, aligning with strength in the Health Care Equipment sector.

2026. júl. 22. 19:46 UTC

Transmedics Group Inc shares are lower today, reflecting ongoing declines. The stock's volatility coincides with rising crude oil prices amid geopolitical tensions.

2026. júl. 21. 14:36 UTC

Social Media

Transmedics Group's shares are higher today following the first lung transplant using its OCS warm-perfusion device, enhancing organ preservation and clinical outcomes.

2026. júl. 20. 12:26 UTC

Social Media

TransMedics Group Inc shares are higher in pre-market trading amid strong operational growth, with flights exceeding 36 per day and projected revenue of $3 billion by 2032.

Társak összehasonlítása

Árváltozás

TransMedics Group Inc Előrejelzés

Célár

By TipRanks

5.44% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 94.22 USD 5.44%

Magas 122 USD

Alacsony 65 USD

10 Wall Street elemző 12 hónapos célárain alapulva a(z)TransMedics Group Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

10 ratings

Vétel

Tartás

Eladás

10 Wall Street elemző célárain alapulva a(z)TransMedics Group Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

323 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.